Er... I'm basing this off a few things.
Last qtr we got ~350K sales and the qtr before in March we got ~435K sales purely from oral devices alone.
With all the deals we have done, I am aware that it will likely be not til Q4 2019 - Q1 2020 where it actually ramps up but still would like to see growth in that area.
AGH with 1500 patients can get ~300K rev off their oil sales.
500K probably high balling it but seems the dental oral devices is not a particularly high growth type of product....
Either way would still like a positive Q3 report... Q4 will be the big one for sure.
- Forums
- ASX - By Stock
- IHL
- Ann: Annual Report to shareholders
Ann: Annual Report to shareholders, page-25
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online